Correction to: Mol Cancer (2017) 16:48
https://doi.org/10.1186/s12943-017-0615-x
After publication of the article [1], the author reported that this article contained some errors.
The photograph of sh-NC in Fig. 1c was misplaced. The correct version of the figure and the figure legend is presented below.
Prognostic value of miR-30d expression in PCa patients and its functions on tumor growth and angiogenesis in vivo using LNCaP cell induced tumor xenografts. a Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival and overall survival of PCa patients based on miR- 30d expression in Taylor and TCGA datasets. b LNCaP cells stably expressing miR-30d formed significantly larger tumor nodules and remarkably speeded up tumor xenografts growth compared with the controls. Conversely, PCa cells that permanently suppressed miR-30d expression led to the smaller tumor nodules and the slower tumor growth compared with the control. c Immunohistochemical analysis using pan-endothelial marker CD31 antibody. d VEGFA protein expression in different groups detected by Western blot analysis. Data were presented as Mean ± SD. *P < 0.05. **P < 0.01
Reference
Lin Z-y, Chen G, Zhang Y-q, He H-c, Liang Y-x, Ye J-h, Liang Y-k, Mo R-j, Jian-ming L, Zhuo Y-j, Zheng Y, Jiang F-n, Han Z-d, Shu-lin W, Zhong W-d, Chin-Lee W. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer. 2017;16:48. https://doi.org/10.1186/s12943-017-0615-x.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The article to which this update relates has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1186/s12943-023-01763-5
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Lin, Zy., Chen, G., Zhang, Yq. et al. Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer 18, 122 (2019). https://doi.org/10.1186/s12943-019-1051-x
Published:
DOI: https://doi.org/10.1186/s12943-019-1051-x